Hypoglycemia Early Alarm Systems Based On Multivariable Models

Kamuran Turksoy1, Elif S Bayrak, Lauretta Quinn

  • 1Department of Biomedical Engineering, Illinois Institute of Technology, 3255 S. Dearborn St., Chicago, IL 60616.

Industrial & Engineering Chemistry Research
|November 5, 2013
PubMed

Insights

This study introduces new time series models for artificial pancreas systems to predict and prevent hypoglycemia in Type 1 diabetes (T1D). The developed alarm system effectively warns patients, enabling timely action to avoid low blood glucose events.

Area of Science:

  • Biomedical Engineering
  • Endocrinology
  • Data Science

Background:

  • Hypoglycemia poses a significant challenge for artificial pancreas (AP) systems in Type 1 diabetes (T1D) management.
  • Existing AP alarm systems often rely on recent glucose trends, limiting predictive accuracy.
  • Early and reliable hypoglycemia warnings are crucial for patient safety and AP system usability.

Purpose of the Study:

  • To develop and evaluate subject-specific recursive linear time series models for improved blood glucose prediction.
  • To integrate these models into an early hypoglycemia alarm system for AP users.
  • To assess the system's retrospective performance in predicting and preventing hypoglycemia in T1D patients.

Main Methods:

  • Subject-specific recursive linear time series models were developed to capture glucose variations.
  • Savitzky-Golay and Kalman filters were employed for noise reduction in patient data.
  • An hypoglycemia alarm algorithm was created using predicted future glucose concentrations from the recursive models.

Main Results:

  • The developed models demonstrated satisfactory glucose concentration prediction with relatively small errors.
  • The modeling algorithm dynamically adapted to inter-/intra-subject variations and glycemic disturbances.
  • The hypoglycemia alarm system showed good performance in predicting and preventing hypoglycemia events.

Conclusions:

  • Subject-specific recursive linear time series models offer a superior alternative for glucose prediction in AP systems.
  • The integrated alarm system effectively predicts and helps prevent hypoglycemia, enhancing AP system safety.
  • This approach holds promise for improving the management of Type 1 diabetes using artificial pancreas technology.

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
34
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
35
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
7.6K
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
32
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.4K